Mylan submits new drug application to FDA

A treatment for COPD was developed by the company and England-based Theravance Biopharma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.